These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 30099225)
1. Impact of uterine fibroids on quality of life: a national cross-sectional survey. Hervé F; Katty A; Isabelle Q; Céline S Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225 [TBL] [Abstract][Full Text] [Related]
2. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey. Soliman AM; Margolis MK; Castelli-Haley J; Fuldeore MJ; Owens CD; Coyne KS Curr Med Res Opin; 2017 Nov; 33(11):1971-1978. PubMed ID: 28836862 [TBL] [Abstract][Full Text] [Related]
3. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Harding G; Coyne KS; Thompson CL; Spies JB Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505 [TBL] [Abstract][Full Text] [Related]
4. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire. Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082 [TBL] [Abstract][Full Text] [Related]
5. Further validation of the uterine fibroid symptom and quality-of-life questionnaire. Coyne KS; Margolis MK; Bradley LD; Guido R; Maxwell GL; Spies JB Value Health; 2012 Jan; 15(1):135-42. PubMed ID: 22264981 [TBL] [Abstract][Full Text] [Related]
6. Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire: a Chinese translation and validation study. Yeung SY; Kwok JWK; Law SM; Chung JPW; Chan SSC Hong Kong Med J; 2019 Dec; 25(6):453-459. PubMed ID: 31796639 [TBL] [Abstract][Full Text] [Related]
7. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials. Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871 [TBL] [Abstract][Full Text] [Related]
8. Uterine fibroids: a review of health-related quality of life assessment. Williams VS; Jones G; Mauskopf J; Spalding J; DuChane J J Womens Health (Larchmt); 2006 Sep; 15(7):818-29. PubMed ID: 16999637 [TBL] [Abstract][Full Text] [Related]
9. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950 [TBL] [Abstract][Full Text] [Related]
10. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey). Koga K; Fukui M; Fujisawa M; Suzukamo Y J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334 [TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in pregnancy with uterine fibroid: a cross-sectional study in China. Ming WK; Wu H; Wu Y; Chen H; Meng T; Shen Y; Wang Z; Huang X; Sun W; Chow TS; Wang Y; Ding W; Chen H; Li Z; Wang Z Health Qual Life Outcomes; 2019 May; 17(1):89. PubMed ID: 31126289 [TBL] [Abstract][Full Text] [Related]
12. Burden of symptomatic uterine fibroids in Canadian women: a cohort study. Laberge PY; Vilos GA; Vilos AG; Janiszewski PM Curr Med Res Opin; 2016; 32(1):165-75. PubMed ID: 26455364 [TBL] [Abstract][Full Text] [Related]
13. Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary. Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A J Comp Eff Res; 2024 Aug; 13(8):e230194. PubMed ID: 38934918 [TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids. Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China. Liu H; Zhang J; Han ZY; Zhang BS; Zhang W; Qi CS; Yu SY; Li HZ; Su HH; Duan XM; Li QY; Li XM; Xu RF Int J Hyperthermia; 2016 Dec; 32(8):876-880. PubMed ID: 27405972 [TBL] [Abstract][Full Text] [Related]
16. A systematic review of the psychosocial impact of fibroids before and after treatment. Go VAA; Thomas MC; Singh B; Prenatt S; Sims H; Blanck JF; Segars JH Am J Obstet Gynecol; 2020 Nov; 223(5):674-708.e8. PubMed ID: 32474012 [TBL] [Abstract][Full Text] [Related]
17. Assessing burden, risk factors, and perceived impact of uterine fibroids on women's lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study. Millien C; Manzi A; Katz AM; Gilbert H; Smith Fawzi MC; Farmer PE; Mukherjee J Int J Equity Health; 2021 Jan; 20(1):1. PubMed ID: 33386078 [TBL] [Abstract][Full Text] [Related]
18. Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study. Keizer AL; van Kesteren PJM; Terwee C; de Lange ME; Hehenkamp WJK; Kok HS BMJ Open; 2021 Nov; 11(11):e052664. PubMed ID: 34815284 [TBL] [Abstract][Full Text] [Related]
19. [Prevalence of uterine fibroids in France and impact on quality of life: results of a survey among 2500 women between 30-55 years]. Fernandez H; Chabbert Buffet N; Allouche S J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):721-7. PubMed ID: 25124196 [TBL] [Abstract][Full Text] [Related]
20. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research. Coyne KS; Margolis MK; Murphy J; Spies J Value Health; 2012; 15(5):674-9. PubMed ID: 22867776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]